V009-8337 Screening compound: 2-benzyl-4-(2,4-difluorophenyl)-N6-[2-(morpholin-4-yl)ethyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

V009-8337 Screening compound: 2-benzyl-4-(2,4-difluorophenyl)-N6-[2-(morpholin-4-yl)ethyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine
V009-8337 Screening compound: 2-benzyl-4-(2,4-difluorophenyl)-N6-[2-(morpholin-4-yl)ethyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine alternative view

Chemical Structure Depiction of ChemDiv screening compound V009-8337
2-benzyl-4-(2,4-difluorophenyl)-N6-[2-(morpholin-4-yl)ethyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V009-8337

Molecular Formula

C24H25F2N7O (C24 H25 F2 N7 O)

Compound Name

2-benzyl-4-(2,4-difluorophenyl)-N6-[2-(morpholin-4-yl)ethyl]-2H-pyrazolo[3,4-d]pyrimidine-3,6-diamine

IUPAC name

2-benzyl-4-(24-difluorophenyl)-N6-[2-(morpholin-4-yl)ethyl]-2H-pyrazolo[34-d]pyrimidine-36-diamine

SMILES

Nc1c2c(-c(ccc(F)c3)c3F)nc(NCCN3CCOCC3)nc2nn1Cc1ccccc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

465.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.248

Distribution Coefficient, logD

3.159

Water Solubility, LogSw

-3.70

Polar Surface Area

76.407

Acid Dissociation Constant (pKa)

16.99

Base Dissociation Constant (pKb)

6.76

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.20

V009-8337 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

PI3K-Targeted Library (17255 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V009-8337 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V009-8337?
Check Price and Availability of V009-8337, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V009-8337 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V009-8337
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V009-8337
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V009-8337 available by request